Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Alopecia areata may be linked to heart issues.

New treatments focusing on immune pathways show promise for stubborn hair loss.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Hair follicles prevent NK cell attacks to avoid hair loss.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.